ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 157 filers reported holding ASCENDIS PHARMA A/S in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,144,808 | +7.4% | 140,376 | +2.4% | 0.00% | 0.0% |
Q2 2023 | $12,240,193 | +50.2% | 137,145 | +80.5% | 0.00% | 0.0% |
Q1 2023 | $8,148,000 | +86830.5% | 75,997 | -1.0% | 0.00% | 0.0% |
Q4 2022 | $9,373 | -99.9% | 76,744 | -15.8% | 0.00% | 0.0% |
Q3 2022 | $9,410,000 | -18.5% | 91,119 | -26.6% | 0.00% | -50.0% |
Q2 2022 | $11,546,000 | +423.2% | 124,211 | +560.4% | 0.00% | – |
Q1 2022 | $2,207,000 | -5.0% | 18,809 | +8.9% | 0.00% | – |
Q4 2021 | $2,324,000 | +109.2% | 17,279 | +148.2% | 0.00% | – |
Q3 2021 | $1,111,000 | +45.8% | 6,962 | +20.3% | 0.00% | – |
Q2 2021 | $762,000 | -86.7% | 5,789 | -87.0% | 0.00% | -100.0% |
Q1 2021 | $5,733,000 | +305.7% | 44,488 | +425.1% | 0.00% | – |
Q4 2020 | $1,413,000 | -83.7% | 8,472 | -85.1% | 0.00% | -100.0% |
Q3 2020 | $8,661,000 | +49.1% | 56,883 | +44.8% | 0.00% | 0.0% |
Q2 2020 | $5,809,000 | +43.8% | 39,272 | +9.5% | 0.00% | 0.0% |
Q1 2020 | $4,039,000 | +59.8% | 35,870 | +97.5% | 0.00% | – |
Q4 2019 | $2,527,000 | +263.1% | 18,165 | +151.4% | 0.00% | – |
Q3 2019 | $696,000 | -87.5% | 7,225 | -86.0% | 0.00% | -100.0% |
Q2 2019 | $5,581,000 | +46.7% | 51,484 | +59.3% | 0.00% | 0.0% |
Q1 2019 | $3,804,000 | +6240.0% | 32,324 | +3693.9% | 0.00% | – |
Q3 2018 | $60,000 | -76.5% | 852 | -78.1% | 0.00% | – |
Q1 2018 | $255,000 | -96.4% | 3,899 | -98.1% | 0.00% | -100.0% |
Q3 2017 | $7,163,000 | – | 201,781 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |